Rh(III)-Catalyzed [4+3] Annulation: Temperature Dependent Ste-reodivergent Synthesis of Point-Planar Chiral Ferrocene Fused Azepines

16 July 2024, Version 3
This content is a preprint and has not undergone peer review at the time of posting.

Abstract

Planar chiral ferrocenes are extensively researched molecules in the fields of asymmetric catalysis, materials science, and medicinal chemistry. Yet, achieving complete control over planar and point chirality simultaneously in a single step remains challenging. Herein, we disclose the first temperature-dependent stereodivergent [4+3] annulation of ferrocene-p-tosylamides via C-H activation with allenes by Rh-catalyst. At room temperature, Rh-catalyzed [4+3] annulation selectively offered one diastereomer (>20:1 dr), whereas at 60 ᵒC, another diastereomer was obtained exclusively with >20:1 dr. Further, [4+3] annulation reaction in the presence of a chiral RhCpX catalyst yielded chiral thermodynamic controlled ferrocenyl azepines up to 84% yield and 96:4 er and chiral kinetically controlled ferrocenyl azepines upto 55% and 97:3 er. The control experiments, isotopic labelling study, and DFT calculations suggested that the reaction proceeds via a σ-bonded rhodacycle avoiding steric repulsion between the phenyl ring of allene and Cp of Rh-catalyst. Which upon reductive elimination offered a kinetically controlled diastereomer at room temperature. Under heating (60 ᵒC) conditions, kinetically controlled diastereomer undergo C-N bond ring opening to afford completely thermodynamically controlled diastereomer and this conversion has also been observed experimentally on isolated kinetically controlled diastereomer.

Keywords

[4+3] Annulation
Allenes
Enantioselectivity
Stereodivergent
Planar chiral Ferrocene

Comments

Comments are not moderated before they are posted, but they can be removed by the site moderators if they are found to be in contravention of our Commenting Policy [opens in a new tab] - please read this policy before you post. Comments should be used for scholarly discussion of the content in question. You can find more information about how to use the commenting feature here [opens in a new tab] .
This site is protected by reCAPTCHA and the Google Privacy Policy [opens in a new tab] and Terms of Service [opens in a new tab] apply.